Compile Data Set for Download or QSAR
Report error Found 57 of affinity data for UniProtKB/TrEMBL: Q9NR63
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50253810BDBM50253810(R115866 | CHEMBL459505 | N-(4-(2-ethyl-1-(1H-1,2,4...)
Affinity DataIC50: 0.460nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2020
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50253810BDBM50253810(R115866 | CHEMBL459505 | N-(4-(2-ethyl-1-(1H-1,2,4...)
Affinity DataIC50: 0.460nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 393281BDBM393281(US9963439, R116010)
Affinity DataIC50: 3.10nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2020
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50157605BDBM50157605(Liazal | R-75251 | Liarozole | US9963439, Liarozol...)
Affinity DataIC50: 18nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50157605BDBM50157605(Liazal | R-75251 | Liarozole | US9963439, Liarozol...)
Affinity DataIC50: 18nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2020
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 151585BDBM151585(US8987315, Ketoconazole | US9180183, Ketoconazole ...)
Affinity DataIC50: 140nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2020
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 557292BDBM557292(US11358933, Compound 026)
Affinity DataIC50: 200nMAssay Description:CYP26 inhibitory activities of various compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 476235BDBM476235(US10874634, Cmpd No. 17 | US11364220, Compound 17)
Affinity DataIC50: 290nMAssay Description:This retinoid activity assay measures the ability of test compounds to induce expression of a transiently transfected RA sensitive reporter construct...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 557299BDBM557299(US11358933, Compound 034)
Affinity DataIC50: 500nMAssay Description:CYP26 inhibitory activities of various compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 31886BDBM31886(CHEMBL309282 | CD564)
Affinity DataIC50: 520nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 476228BDBM476228(US10874634, Cmpd No. 10 | US11364220, Compound 10)
Affinity DataIC50: 550nMAssay Description:This retinoid activity assay measures the ability of test compounds to induce expression of a transiently transfected RA sensitive reporter construct...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50157722BDBM50157722(CHEMBL3787323)
Affinity DataIC50: 680nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50157724BDBM50157724(CHEMBL3787564 | US9963439, Compound B)
Affinity DataIC50: 930nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50157727BDBM50157727(CHEMBL3786184)
Affinity DataIC50: 1.03E+3nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50157721BDBM50157721(CHEMBL3786620)
Affinity DataIC50: 1.03E+3nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50033067BDBM50033067(4-[2-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-napht...)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50157731BDBM50157731(CHEMBL3785511 | US9963439, Compound C)
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50157729BDBM50157729(CHEMBL3787691)
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50157604BDBM50157604(CHEMBL3786324)
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 476180BDBM476180(US10874634, Cmpd No. 02 | US11364220, Compound 02)
Affinity DataIC50: 2.06E+3nMAssay Description:This retinoid activity assay measures the ability of test compounds to induce expression of a transiently transfected RA sensitive reporter construct...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 557298BDBM557298(US11358933, Compound 032)
Affinity DataIC50: 2.30E+3nMAssay Description:CYP26 inhibitory activities of various compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50157718BDBM50157718(CHEMBL3785701)
Affinity DataIC50: 4.40E+3nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50157608BDBM50157608(CHEMBL95949)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50157728BDBM50157728(CHEMBL3785761)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50157730BDBM50157730(CHEMBL3785557)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50157719BDBM50157719(CHEMBL3785624)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50157723BDBM50157723(CHEMBL3786927)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50157726BDBM50157726(CHEMBL3786043)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50032675BDBM50032675(4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaph...)
Affinity DataIC50: 5.90E+3nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50157720BDBM50157720(CHEMBL3786340)
Affinity DataIC50: 6.20E+3nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 557293BDBM557293(US11358933, Compound 027)
Affinity DataIC50: 8.80E+3nMAssay Description:CYP26 inhibitory activities of various compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 476173BDBM476173(US10874634, Cmpd No. 01 | US11364220, Compound 01)
Affinity DataIC50: 8.81E+3nMAssay Description:This retinoid activity assay measures the ability of test compounds to induce expression of a transiently transfected RA sensitive reporter construct...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 476236BDBM476236(US10874634, Cmpd No. 18 | US11364220, Compound 18)
Affinity DataIC50: 9.07E+3nMAssay Description:This retinoid activity assay measures the ability of test compounds to induce expression of a transiently transfected RA sensitive reporter construct...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50157717BDBM50157717(CHEMBL3786581)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 476222BDBM476222(US10874634, Cmpd No. 05 | US11364220, Compound 05)
Affinity DataIC50: 1.15E+4nMAssay Description:This retinoid activity assay measures the ability of test compounds to induce expression of a transiently transfected RA sensitive reporter construct...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 476234BDBM476234(US10874634, Cmpd No. 16 | US11364220, Compound 16)
Affinity DataIC50: 1.19E+4nMAssay Description:This retinoid activity assay measures the ability of test compounds to induce expression of a transiently transfected RA sensitive reporter construct...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50033077BDBM50033077(4-[2-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-napht...)
Affinity DataIC50: 1.26E+4nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 476226BDBM476226(US10874634, Cmpd No. 09 | US11364220, Compound 09)
Affinity DataIC50: 1.42E+4nMAssay Description:This retinoid activity assay measures the ability of test compounds to induce expression of a transiently transfected RA sensitive reporter construct...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50157611BDBM50157611(CHEMBL3787627)
Affinity DataIC50: 1.45E+4nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 557291BDBM557291(US11358933, Compound 025)
Affinity DataIC50: 1.79E+4nMAssay Description:CYP26 inhibitory activities of various compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 557297BDBM557297(US11358933, Compound 031)
Affinity DataIC50: 1.83E+4nMAssay Description:CYP26 inhibitory activities of various compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 476217BDBM476217(US10874634, Cmpd No. 04 | US11364220, Compound 04)
Affinity DataIC50: 1.89E+4nMAssay Description:This retinoid activity assay measures the ability of test compounds to induce expression of a transiently transfected RA sensitive reporter construct...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 476225BDBM476225(US10874634, Cmpd No. 08 | US11364220, Compound 08)
Affinity DataIC50: 1.92E+4nMAssay Description:This retinoid activity assay measures the ability of test compounds to induce expression of a transiently transfected RA sensitive reporter construct...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 476238BDBM476238(US10874634, Cmpd No. 21 | US11364220, Compound 21)
Affinity DataIC50: 2.18E+4nMAssay Description:This retinoid activity assay measures the ability of test compounds to induce expression of a transiently transfected RA sensitive reporter construct...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 50033066BDBM50033066(4-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-naphthal...)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/13/2017
Entry Details Article
PubMed
TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 476223BDBM476223(US10874634, Cmpd No. 06 | US11364220, Compound 06)
Affinity DataIC50: 4.23E+4nMAssay Description:This retinoid activity assay measures the ability of test compounds to induce expression of a transiently transfected RA sensitive reporter construct...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 557295BDBM557295(US11358933, Compound 029)
Affinity DataIC50: 5.49E+4nMAssay Description:CYP26 inhibitory activities of various compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 476181BDBM476181(US10874634, Cmpd No. 03 | US11364220, Compound 03)
Affinity DataIC50: 6.54E+4nMAssay Description:This retinoid activity assay measures the ability of test compounds to induce expression of a transiently transfected RA sensitive reporter construct...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 557296BDBM557296(US11358933, Compound 030)
Affinity DataIC50: 8.81E+4nMAssay Description:CYP26 inhibitory activities of various compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2022
Entry Details
US Patent

TargetCytochrome P450 26B1(Human)
University of Washington Through Its Center For Commercialization

US Patent
LigandChemical structure of BindingDB Monomer ID 476237BDBM476237(US10874634, Cmpd No. 19 | US11364220, Compound 19)
Affinity DataIC50: 1.00E+5nMAssay Description:This retinoid activity assay measures the ability of test compounds to induce expression of a transiently transfected RA sensitive reporter construct...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

Displayed 1 to 50 (of 57 total ) | Next | Last >>
Jump to: